Inven2's Idépris 2022 goes to a virtual tool for developing antibodies. The idea was developed by Victor Greiff, head of the convergence environment ImmunoLingo, together with colleagues from the University of Oslo and Oslo University Hospital.
/University of Oslo Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
